Company Report
Last edited 6 months ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#135
Performance (52m)
-15.4% pa
Followed by
155
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#FDA APPROVAL
stale
Added 6 months ago

FDA A{{ROVAL GRANTED

Good Luck to all who hold!


Held i

#Study Results #2A 3/2/21
stale
Added 4 years ago

Phase 2a Study Shows BTX 1801 Eradicates Staphylococcus Aureus

• Top-line data showed that two different BTX 1801 formulations (ointment and gel) were safe, well tolerated and successful at eradicating Staphylococcus aureus.

• Eradication rates as high as 76.2% were obtained at Day 7 for BTX 1801 ointment, with eradication effects extending through to Day 28 of the study to 23.8%, despite no treatment after Day 5

• Botanix continues to assess the clinical utility of synthetic CBD for the treatment of a variety of infections and also develop its proprietary CBD analog assets

View Attachment